|
1
|
Kondo Y, Kanzawa T, Sawaya R and Kondo S:
The role of autophagy in cancer development and response to
therapy. Nat Rev Cancer. 5:726–734. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mizushima N, Ohsumi Y and Yoshimori T:
Autophagosome formation in mammalian cells. Cell Struct Funct.
27:421–429. 2002. View Article : Google Scholar
|
|
3
|
Kabeya Y, Mizushima N, Ueno T, Yamamoto A,
Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T: LC3, a
mammalian homologue of yeast Apg8p, is localized in autophagosome
membranes after processing. EMBO J. 19:5720–5728. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mizushima N, Yoshimori T and Levine B:
Methods in mammalian autophagy research. Cell. 140:313–326. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mathew R, Karantza-Wadsworth V and White
E: Role of autophagy in cancer. Nat Rev Cancer. 7:961–967. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Giatromanolaki A, Koukourakis MI, Harris
AL, Polychronidis A, Gatter KC and Sivridis E: Prognostic relevance
of light chain 3 (LC3A) autophagy patterns in colorectal
adenocarcinomas. J Clin Pathol. 63:867–872. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park JM, Huang S, Wu TT, Foster NR and
Sinicrope FA: Prognostic impact of beclin 1, p62/sequestosome 1 and
LC3 protein expression in colon carcinomas from patients receiving
5-fluorouracil as adjuvant chemotherapy. Cancer Biol Ther.
14:100–107. 2013. View Article : Google Scholar :
|
|
8
|
Buermeyer AB, Deschênes SM, Baker SM and
Liskay RM: Mammalian DNA mismatch repair. Annu Rev Genet.
33:533–564. 1999. View Article : Google Scholar
|
|
9
|
Jacob S and Praz F: DNA mismatch repair
defects: Role in colorectal carcinogenesis. Biochimie. 84:27–47.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Modrich P and Lahue R: Mismatch repair in
replication fidelity, genetic recombination, and cancer biology.
Annu Rev Biochem. 65:101–133. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fink D, Aebi S and Howell SB: The role of
DNA mismatch repair in drug resistance. Clin Cancer Res. 4:1–6.
1998.PubMed/NCBI
|
|
12
|
Stojic L, Brun R and Jiricny J: Mismatch
repair and DNA damage signalling. DNA Repair (Amst). 3:1091–1101.
2004. View Article : Google Scholar
|
|
13
|
Sato K, Tsuchihara K, Fujii S, Sugiyama M,
Goya T, Atomi Y, Ueno T, Ochiai A and Esumi H: Autophagy is
activated in colorectal cancer cells and contributes to the
tolerance to nutrient deprivation. Cancer Res. 67:9677–9684. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Longley DB, Harkin DP and Johnston PG:
5-fluorouracil: Mechanisms of action and clinical strategies. Nat
Rev Cancer. 3:330–338. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li J, Hou N, Faried A, Tsutsumi S,
Takeuchi T and Kuwano H: Inhibition of autophagy by 3-MA enhances
the effect of 5-FU-induced apoptosis in colon cancer cells. Ann
Surg Oncol. 16:761–771. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li J, Hou N, Faried A, Tsutsumi S and
Kuwano H: Inhibition of autophagy augments 5-fluorouracil
chemotherapy in human colon cancer in vitro and in vivo model. Eur
J Cancer. 46:1900–1909. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sui X, Chen R, Wang Z, Huang Z, Kong N,
Zhang M, Han W, Lou F, Yang J, Zhang Q, et al: Autophagy and
chemotherapy resistance: A promising therapeutic target for cancer
treatment. Cell Death Dis. 4:e8382013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Suraweera N, Duval A, Reperant M, Vaury C,
Furlan D, Leroy K, Seruca R, Iacopetta B and Hamelin R: Evaluation
of tumor microsatellite instability using five quasimonomorphic
mono-nucleotide repeats and pentaplex PCR. Gastroenterology.
123:1804–1811. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xicola RM, Llor X, Pons E, Castells A,
Alenda C, Piñol V, Andreu M, Castellví-Bel S, Payá A, Jover R, et
al Gastrointestinal Oncology Group of the Spanish
Gastroenterological Association: Performance of different
microsatellite marker panels for detection of mismatch
repair-deficient colorectal tumors. J Natl Cancer Inst. 99:244–252.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Deschoolmeester V, Baay M, Wuyts W, Van
Marck E, Van Damme N, Vermeulen P, Lukaszuk K, Lardon F and
Vermorken JB: Detection of microsatellite instability in colorectal
cancer using an alternative multiplex assay of quasi-monomorphic
mononucleotide markers. J Mol Diagn. 10:154–159. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pedroni M, Roncari B, Maffei S, Losi L,
Scarselli A, Di Gregorio C, Marino M, Roncucci L, Benatti P, Ponti
G, et al: A mononucleotide markers panel to identify hMLH1/hMSH2
germline mutations. Dis Markers. 23:179–187. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mariani F, Sena P, Pedroni M, Benatti P,
Manni P, Di Gregorio C, Manenti A, Palumbo C, de Leon MP and
Roncucci L: Th inducing POZ-Kruppel Factor (ThPOK) is a key
regulator of the immune response since the early steps of
colorectal carcinogenesis. PLoS One. 8:e544882013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mizushima N, Levine B, Cuervo AM and
Klionsky DJ: Autophagy fights disease through cellular
self-digestion. Nature. 451:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liang XH, Jackson S, Seaman M, Brown K,
Kempkes B, Hibshoosh H and Levine B: Induction of autophagy and
inhibition of tumorigenesis by beclin 1. Nature. 402:672–676. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang J: Beclin 1 bridges autophagy,
apoptosis and differentiation. Autophagy. 4:947–948. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mariani F, Sena P, Marzona L, Riccio M,
Fano R, Manni P, Gregorio CD, Pezzi A, Leon MP, Monni S, et al:
Cyclooxygenase-2 and hypoxia-inducible factor-1alpha protein
expression is related to inflammation, and up-regulated since the
early steps of colorectal carcinogenesis. Cancer Lett. 279:221–229.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Beasley NJ, Wykoff CC, Watson PH, Leek R,
Turley H, Gatter K, Pastorek J, Cox GJ, Ratcliffe P and Harris AL:
Carbonic anhydrase IX, an endogenous hypoxia marker, expression in
head and neck squamous cell carcinoma and its relationship to
hypoxia, necrosis, and microvessel density. Cancer Res.
61:5262–5267. 2001.PubMed/NCBI
|
|
28
|
Mizushima N: Methods for monitoring
autophagy. Int J Biochem Cell Biol. 36:2491–2502. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jin S and White E: Role of autophagy in
cancer: Management of metabolic stress. Autophagy. 3:28–31. 2007.
View Article : Google Scholar
|
|
30
|
Giatromanolaki A, Koukourakis MI,
Koutsopoulos AV, Harris AL, Gatter KC and Sivridis E: Autophagy and
hypoxia in colonic adenomas related to aggressive features.
Colorectal Dis. 15:e223–e230. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sena P, Roncucci L, Marzona L, Mariani F,
Maffei S, Manenti A and De Pol A: Altered expression of apoptosis
biomarkers in human colorectal microadenomas. Cancer Epidemiol
Biomarkers Prev. 19:351–357. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Inbal B, Bialik S, Sabanay I, Shani G and
Kimchi A: DAP kinase and DRP-1 mediate membrane blebbing and the
formation of autophagic vesicles during programmed cell death. J
Cell Biol. 157:455–468. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Degenhardt K, Mathew R, Beaudoin B, Bray
K, Anderson D, Chen G, Mukherjee C, Shi Y, Gélinas C, Fan Y, et al:
Autophagy promotes tumor cell survival and restricts necrosis,
inflammation, and tumorigenesis. Cancer Cell. 10:51–64. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Amaravadi RK, Yu D, Lum JJ, Bui T,
Christophorou MA, Evan GI, Thomas-Tikhonenko A and Thompson CB:
Autophagy inhibition enhances therapy-induced apoptosis in a
Myc-induced model of lymphoma. J Clin Invest. 117:326–336. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yoshioka A, Miyata H, Doki Y, Yamasaki M,
Sohma I, Gotoh K, Takiguchi S, Fujiwara Y, Uchiyama Y and Monden M:
LC3, an autophagosome marker, is highly expressed in
gastrointestinal cancers. Int J Oncol. 33:461–468. 2008.PubMed/NCBI
|
|
36
|
Guo GF, Jiang WQ, Zhang B, Cai YC, Xu RH,
Chen XX, Wang F and Xia LP: Autophagy-related proteins Beclin-1 and
LC3 predict cetuximab efficacy in advanced colorectal cancer. World
J Gastroenterol. 17:4779–4786. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Miao Y, Zhang Y, Chen Y, Chen L and Wang
F: GABARAP is over-expressed in colorectal carcinoma and correlates
with shortened patient survival. Hepatogastroenterology.
57:257–261. 2010.PubMed/NCBI
|
|
38
|
White E, Karp C, Strohecker AM, Guo Y and
Mathew R: Role of autophagy in suppression of inflammation and
cancer. Curr Opin Cell Biol. 22:212–217. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen N and Karantza V: Autophagy as a
therapeutic target in cancer. Cancer Biol Ther. 11:157–168. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hönscheid P, Datta K and Muders MH:
Autophagy: Detection, regulation and its role in cancer and therapy
response. Int J Radiat Biol. 90:628–635. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
van Lier MG, Leenen CH, Wagner A, Ramsoekh
D, Dubbink HJ, van den Ouweland AM, Westenend PJ, de Graaf EJ,
Wolters LM, Vrijland WW, et al LIMO Study Group: Yield of routine
molecular analyses in colorectal cancer patients ≤70 years to
detect underlying Lynch syndrome. J Pathol. 226:764–774. 2012.
View Article : Google Scholar
|
|
42
|
Jass JR, Do KA, Simms LA, Iino H, Wynter
C, Pillay SP, Searle J, Radford-Smith G, Young J and Leggett B:
Morphology of sporadic colorectal cancer with DNA replication
errors. Gut. 42:673–679. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Thibodeau SN, Bren G and Schaid D:
Microsatellite instability in cancer of the proximal colon.
Science. 260:816–819. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lothe RA, Peltomäki P, Meling GI, Aaltonen
LA, Nyström- Lahti M, Pylkkänen L, Heimdal K, Andersen TI, Møller
P, Rognum TO, et al: Genomic instability in colorectal cancer:
Relationship to clinicopathological variables and family history.
Cancer Res. 53:5849–5852. 1993.PubMed/NCBI
|
|
45
|
Choi SW, Lee KJ, Bae YA, Min KO, Kwon MS,
Kim KM and Rhyu MG: Genetic classification of colorectal cancer
based on chromosomal loss and microsatellite instability predicts
survival. Clin Cancer Res. 8:2311–2322. 2002.PubMed/NCBI
|
|
46
|
Halling KC, French AJ, McDonnell SK,
Burgart LJ, Schaid DJ, Peterson BJ, Moon-Tasson L, Mahoney MR,
Sargent DJ, O'Connell MJ, et al: Microsatellite instability and 8p
allelic imbalance in stage B2 and C colorectal cancers. J Natl
Cancer Inst. 91:1295–1303. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hemminki A, Mecklin JP, Järvinen H,
Aaltonen LA and Joensuu H: Microsatellite instability is a
favorable prognostic indicator in patients with colorectal cancer
receiving chemotherapy. Gastroenterology. 119:921–928. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Samowitz WS, Curtin K, Ma KN, Schaffer D,
Coleman LW, Leppert M and Slattery ML: Microsatellite instability
in sporadic colon cancer is associated with an improved prognosis
at the population level. Cancer Epidemiol Biomarkers Prev.
10:917–923. 2001.PubMed/NCBI
|
|
49
|
Watanabe T, Wu TT, Catalano PJ, Ueki T,
Satriano R, Haller DG, Benson AB III and Hamilton SR: Molecular
predictors of survival after adjuvant chemotherapy for colon
cancer. N Engl J Med. 344:1196–1206. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Salazar R, Roepman P, Capella G, Moreno V,
Simon I, Dreezen C, Lopez-Doriga A, Santos C, Marijnen C, Westerga
J, et al: Gene expression signature to improve prognosis prediction
of stage II and III colorectal cancer. J Clin Oncol. 29:17–24.
2011. View Article : Google Scholar
|
|
51
|
Gray RG, Quirke P, Handley K, Lopatin M,
Magill L, Baehner FL, Beaumont C, Clark-Langone KM, Yoshizawa CN,
Lee M, et al: Validation study of a quantitative multigene reverse
transcriptase-polymerase chain reaction assay for assessment of
recurrence risk in patients with stage II colon cancer. J Clin
Oncol. 29:4611–4619. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
O'Connell MJ, Lavery I, Yothers G, Paik S,
Clark-Langone KM, Lopatin M, Watson D, Baehner FL, Shak S, Baker J,
et al: Relationship between tumor gene expression and recurrence in
four independent studies of patients with stage II/III colon cancer
treated with surgery alone or surgery plus adjuvant fluorouracil
plus leucovorin. J Clin Oncol. 28:3937–3944. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Deschoolmeester V, Baay M, Lardon F,
Pauwels P and Peeters M: Immune cells in colorectal cancer:
Prognostic relevance and role of MSI. Cancer Microenviron.
4:377–392. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Eveno C, Nemeth J, Soliman H, Praz F, de
The H, Valleur P, Talbot IC and Pocard M: Association between a
high number of isolated lymph nodes in T1 to T4 N0M0 colorectal
cancer and the microsatellite instability phenotype. Arch Surg.
145:12–17. 2010.PubMed/NCBI
|
|
55
|
Kuperwasser C, Chavarria T, Wu M, Magrane
G, Gray JW, Carey L, Richardson A and Weinberg RA: Reconstruction
of functionally normal and malignant human breast tissues in mice.
Proc Natl Acad Sci USA. 101:4966–4971. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kalluri R: Basement membranes: Structure,
assembly and role in tumour angiogenesis. Nat Rev Cancer.
3:422–433. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Pavlides S, Whitaker-Menezes D,
Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, Casimiro
MC, Wang C, Fortina P, Addya S, et al: The reverse Warburg effect:
Aerobic glycolysis in cancer associated fibroblasts and the tumor
stroma. Cell Cycle. 8:3984–4001. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Bonuccelli G, Tsirigos A, Whitaker-Menezes
D, Pavlides S, Pestell RG, Chiavarina B, Frank PG, Flomenberg N,
Howell A, Martinez-Outschoorn UE, et al: Ketones and lactate 'fuel'
tumor growth and metastasis: Evidence that epithelial cancer cells
use oxidative mitochondrial metabolism. Cell Cycle. 9:3506–3514.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Martinez-Outschoorn UE, Balliet RM,
Rivadeneira DB, Chiavarina B, Pavlides S, Wang C, Whitaker-Menezes
D, Daumer KM, Lin Z, Witkiewicz AK, et al: Oxidative stress in
cancer associated fibroblasts drives tumor-stroma co-evolution: A
new paradigm for understanding tumor metabolism, the field effect
and genomic instability in cancer cells. Cell Cycle. 9:3256–3276.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Worthley DL, Giraud AS and Wang TC:
Stromal fibroblasts in digestive cancer. Cancer Microenviron.
3:117–125. 2010. View Article : Google Scholar
|
